Why trust GLP Chart.
What we measure, who measures it, what we won't take money for, and how we handle being wrong.
How the score is made
How we score
Every program is scored on five pillars: pricing, cancellation, onboarding, medication options, and member feedback. Each pillar is a 0 to 10 sub-score; the overall score is the mean. The scoring rubric, the data we pull, and the verification steps for each pillar are documented on the methodology page. The rubric has not changed since April 1, 2026.
The scoring team
Medical reviewer: actively recruiting. Until contracted, every clinical claim on the site is sourced to a published registration trial or FDA label. The first credentialed MD or DO reviewer with no relationship to any program in the chart joins the team as a named byline on every program and condition page.
Price verification: the editor checks every program's published pricing pages for the maintenance-dose figure and the fulfillment-pharmacy chain it discloses. When a program's site blocks automated access, the published figure is confirmed through a web search of the program's own materials. We do not create accounts or make any purchase to do this.
John Samaras, editor, decides which programs enter the chart, which leave, and how each pillar is weighted. He works on the US GLP-1 telehealth category full time from Austin, Texas, and has since 2026. LinkedIn · About
Independence and money
Paid placements: zero
Rank order is locked before any commercial relationship exists. Where a Visit link is an affiliate link, it is marked sponsored per FTC and Google rules. See the full GLP Chart Pledge for the seven editorial commitments.
How we make money
Affiliate commissions on outbound Visit links when a reader subscribes to a program. A Visit link earns us a commission only when the program runs an affiliate program we can join; many programs in the chart run none at all. The chart shows all of them, ranked by the same rubric. We don't sell placement, sponsored content, email-list rentals, or program-paid posts.
Independence policy
GLP Chart is an independent editorial site. We do not let any program in the chart approve or preview our content before publication. We do not accept gifts, free samples, sponsored trips, consulting fees, or speaking honoraria from any program in the chart or any GLP-1 pharmaceutical manufacturer. The full policy is on the editorial independence page.
When we are wrong
What programs publish
Every monthly maintenance price on the chart was confirmed in the last 30 days against the program's published pricing pages, not a marketing claim or an advertised teaser. We read the maintenance-dose figure the program publishes, and when a program's site blocks automated access we confirm it through a web search of the program's own materials. We cite the published source for every price. When a price moves, the change appears in the weekly What changed this week callout on /latest/ and gets a row in the corrections log.
Corrections log
When we get something wrong, we say so publicly with a date. We do not silently edit a published score or claim. The full corrections log is published with each weekly price check. Recent corrections:
Found a problem?
Email corrections@glpchart.com. We respond within 24 hours on business days. If a published claim is wrong, the correction goes up in the next weekly price check with your name credited (with permission).
Get every price change
We email you the moment a price moves.
We check all 25 programs against published pricing every Monday. When a price moves or a lock-in clause appears, you hear about it first.
Some “Visit” links earn us a commission. Disclosure.
